Pivotal Trial of the Boomerang Catheter for pDVA
Part of paid clinical trials in Sylmar, California.
- Sponsor
- Aveera Medical, Inc.
- Study ID
- NCT06311773
- Status
- Enrolling By Invitation
Conditions
- Chronic Limb-Threatening Ischemia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Boomerang Catheter — DEVICEThe study device used for this procedure makes an anastomosis between a tibial vein and a tibial artery to direct blood flow around blocked arteries.
Study Details
The purpose of this study is to establish the safety and effectiveness of the Boomerang Catheter for percutaneous Deep Venous Arterialization (pDVA) to treat no-option Chronic Limb-Threatening Ischemia.
Key Dates
- Start date
- Apr 16, 2024
- Status verified
- Feb 2026
- Primary completion
- Mar 31, 2027
- Completion
- Mar 31, 2030
Study Design
- Enrollment
- 120 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Treated with Boomerang Catheter
Primary Outcome Measure
Amputation Free Survival (AFS) [ Time Frame: 6-months ]
Locations (19)
Find similar trials in Sylmar, CA
By research site
Olive View-UCLA Medical Center· Sylmar, CALundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center· Torrance, CAPIH Whittier Hospital· Whittier, CAEndoVascular Consultants· Wilmington, DEFirst Coast Cardiovascular Institute· Jacksonville, FLRush University Medical Center· Chicago, IL
Related Studies
- PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening IschemiaRecruiting · LimFlow, Inc. · La Jolla, California
- Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee DiseaseRecruiting · R3 Vascular Inc. · New York, New York
- The ROAMM-EHR StudyRecruiting · University of Florida · Gainesville, Florida
- Peripheral Bypass Trial for Completion ControlRecruiting · Medistim ASA · San Francisco, California